Back
ESC Premium Access

Cardiovascular adverse events associated with BRAF and MEK inhibitors

Session: Poster Session 1 - Cardio-oncology II
Topic: Cardio-Oncology
Speaker: Associate Professor R. Mincu (Essen, DE)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Associate Professor Raluca-Ileana Mincu

University of Duisburg-Essen - West-German Heart and Vascular Centre, Essen (Germany)
0 follower

9 more presentations in this session

The clinical value of CMR in the management of Cardio-Oncology patients - a tertiary centre experience.

Speaker: Doctor J. Chong (Singapore, SG)

Access
Abstract
Slides
Like
Thumbnail

Acute Myocardial Infarction in patients with Leukaemia: A national analysis of prevalence, predictors and outcomes in United States hospitalisations (2004 to 2014)

Speaker: Doctor M. Mohamed (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Radiotherapy-induced malfunction in cancer patients with cardiac implantable electronic devices

Speaker: Doctor J. Imberti (Modena, IT)

Access
Abstract
Slides
Like
Thumbnail

Long-term outcomes in patients with cancer undergoing percutaneous coronary intervention: analysis from a Japan multicenter registry

Speaker: Doctor A. Endo (Tokyo, JP)

Access
Abstract
Like
Thumbnail

Pterostilbene reduces acute doxorubicin cardiotoxicity via enhancing AMPK-SIRT1-PGC1 cascades

Speaker: Doctor D. Liu (Beijing, CN)

Access
Like
Thumbnail

Access the full session

Poster Session 1 - Cardio-oncology II

Speakers: Associate Professor R. Mincu, Doctor J. Chong, Doctor M. Mohamed, Doctor J. Imberti, Doctor A. Endo...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources